Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 107421, 14 pages
http://dx.doi.org/10.1155/2014/107421
Review Article

Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy

1Interdepartmental Research Center of Systemic Autoimmune and Autoinflammatory Diseases, Rheumatology Unit, Policlinico Le Scotte, University of Siena, Viale Bracci 1, 53100 Siena, Italy
2Rheumatology Unit, Department of Medicine DIMED, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
3Rheumatology Unit, Department of Clinical Medicine and Surgery, University Federico II, Via S. Pansini 5, 80131 Naples, Italy
4Institute of Pediatrics, Cattolica Sacro Cuore University, Largo Agostino Gemelli 8, 00168 Rome, Italy
5La Sapienza University, Viale del Policlinico 155, 00161 Rome, Italy
6Department of Pediatrics, Rheumatology Unit, Anna Meyer Children’s Hospital and University of Florence, Viale Pieraccini 24, 50139 Florence, Italy
7Rheumatology Service, Hospital Regional Universitario Carlos Haya, University of Màlaga, Avenida Carlos Haya s/n, 29010 Màlaga, Spain

Received 16 January 2014; Revised 17 April 2014; Accepted 1 May 2014; Published 30 June 2014

Academic Editor: Chiara De Luca

Copyright © 2014 Francesco Caso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [48 citations]

The following is the list of published articles that have cited the current article.

  • Luca Cantarini, Giuseppe Lopalco, Francesco Caso, Luisa Costa, Florenzo Iannone, Giovanni Lapadula, Maria Grazia Anelli, Rossella Franceschini, Cristina Menicacci, Mauro Galeazzi, Carlo Selmi, and Donato Rigante, “Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease,” Autoimmunity Reviews, 2014. View at Publisher · View at Google Scholar
  • Onder Akci, Mustafa Aldemir, Fatma Yaman, Ozlem Solak, Sadık Volkan Emren, Ersel Onrat, and Alaeddin Avsar, “Assessment of Cardiac Autonomic Function by Using Heart Rate Turbulence in Behcet’s Disease,” World Journal of Cardiovascular Surgery, vol. 04, no. 11, pp. 193–199, 2014. View at Publisher · View at Google Scholar
  • D. P. Kidd, “Rituximab is effective in severe treatment-resistant neurological Behçet’s syndrome,” Journal of Neurology, 2015. View at Publisher · View at Google Scholar
  • Luca Cantarini, Rosaria Talarico, Elena Generali, Giacomo Emmi, Giuseppe Lopalco, Luisa Costa, Elena Silvestri, Francesco Caso, Rossella Franceschini, Rolando Cimaz, Florenzo Iannone, Mauro Galeazzi, and Carlo Selmi, “Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study,” International Journal of Rheumatic Diseases, 2015. View at Publisher · View at Google Scholar
  • Dorit Shitenberg, Oren Fruchter, Ludmila Fridel, and Mordechai R. Kramer, “Successful Rituximab therapy in steroid-resistant, cryptogenic organizing pneumonia: A case series,” Respiration, vol. 90, no. 2, pp. 155–159, 2015. View at Publisher · View at Google Scholar
  • Giacomo Emmi, Rosaria Talarico, Giuseppe Lopalco, Rolando Cimaz, Fabrizio Cantini, Ombretta Viapiana, Ignazio Olivieri, Matteo Goldoni, Antonio Vitale, Elena Silvestri, Domenico Prisco, Giovanni Lapadula, Mauro Galeazzi, Florenzo Iannone, and Luca Cantarini, “Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study,” Clinical Rheumatology, 2015. View at Publisher · View at Google Scholar
  • Antonio Vitale, Donato Rigante, Francesco Caso, Rossella Franceschini, and Luca Cantarini, “Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection,” International Journal of Rheumatic Diseases, 2015. View at Publisher · View at Google Scholar
  • Rosaria Talarico, Luca Cantarini, Anna d’Ascanio, Michele Figus, Benedetta Favati, Chiara Baldini, Chiara Tani, R. Neri, Stefano Bombardieri, and Marta Mosca, “Development of de novo major involvement during follow-up in Behçet’s syndrome,” Clinical Rheumatology, 2015. View at Publisher · View at Google Scholar
  • Giuseppe Lopalco, Orso Maria Lucherini, Antonio Vitale, Rosaria Talarico, Antonio Lopalco, Mauro Galeazzi, Giovanni Lapadula, Luca Cantarini, and Florenzo Iannone, “Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcetʼs Disease,” Medicine, vol. 94, no. 42, pp. e1858, 2015. View at Publisher · View at Google Scholar
  • Elena Generali, Luca Cantarini, and Carlo Selmi, “Ocular Involvement in Systemic Autoimmune Diseases,” Clinical Reviews in Allergy & Immunology, 2015. View at Publisher · View at Google Scholar
  • Eleni I. Kampylafka, Harry Alexopoulos, Marinos C. Dalakas, and Athanasios G. Tzioufas, “Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity,” Neurotherapeutics, 2015. View at Publisher · View at Google Scholar
  • Giuseppe Lopalco, Luca Cantarini, Antonio Vitale, Florenzo Iannone, Maria Grazia Anelli, Laura Andreozzi, Giovanni Lapadula, Mauro Galeazzi, and Donato Rigante, “Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives,” Mediators of Inflammation, vol. 2015, pp. 1–21, 2015. View at Publisher · View at Google Scholar
  • Cinzia Rotondo, Giuseppe Lopalco, Florenzo Iannone, Antonio Vitale, Rosaria Talarico, Mauro Galeazzi, Giovanni Lapadula, and Luca Cantarini, “Mucocutaneous Involvement in Behçet’s Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives,” Mediators of Inflammation, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Yung-Ray Hsu, Shu-Wen Chang, Yu-Cheng Lin, and Chang-Hao Yang, “Expression of MicroRNAs in the Eyes of Lewis Rats with Experimental Autoimmune Anterior Uveitis,” Mediators of Inflammation, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Marco Cattalini, Martina Soliani, Donato Rigante, Giuseppe Lopalco, Florenzo Iannone, Mauro Galeazzi, and Luca Cantarini, “Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease,” Mediators of Inflammation, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco, Stefano Gentileschi, Elena Silvestri, Claudia Fabiani, Maria Letizia Urban, Bruno Frediani, Mauro Galeazzi, Florenzo Iannone, Donato Rigante, and Luca Cantarini, “Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study,” Clinical Rheumatology, 2016. View at Publisher · View at Google Scholar
  • Tamer A Gheita, Heba A Gheita, and Sanaa A Kenawy, “The potential of genetically guided treatment in Behçet's disease,” Pharmacogenomics, 2016. View at Publisher · View at Google Scholar
  • Chandini Ravikumar, Gayathri Devi, and Karthikeyan Murthykumar, “Behcets syndrome: A Review,” Research Journal of Pharmacy and Technology, vol. 9, no. 3, pp. 296–297, 2016. View at Publisher · View at Google Scholar
  • Francesco Caso, Antonio Del Puente, Rosario Peluso, Paolo Caso, Nicolò Girolimetto, Aurora Del Puente, Raffaele Scarpa, and Luisa Costa, “Emerging drugs for psoriatic arthritis,” Expert Opinion on Emerging Drugs, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • L. Cantarini, V. Pucino, A. Vitale, R. Talarico, O. M. Lucherini, F. Magnotti, V. De Rosa, M. Galgani, C. Alviggi, G. Marone, M. Galeazzi, and G. Matarese, “Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens,” Clinical & Experimental Immunology, vol. 184, no. 2, pp. 197–207, 2016. View at Publisher · View at Google Scholar
  • Katherine L. Johnson, and Marla N. Jahnke, “Cutaneous Manifestations of Systemic Disease,” Therapy in Pediatric Dermatology, pp. 421–443, 2016. View at Publisher · View at Google Scholar
  • Hee Jung Ryu, Mi Ryoung Seo, Hyo Jin Choi, Kwang-Pil Ko, Pil Whan Park, and Han Joo Baek, “Mean platelet volume as a marker for differentiating disease flare from infection in Behçet's disease,” International Journal of Rheumatic Diseases, 2016. View at Publisher · View at Google Scholar
  • Claudia Fabiani, Florenzo Iannone, Luca Cantarini, Giuseppe Lopalco, Lorenzo Vannozzi, Silvana Guerriero, Rossella Franceschini, Bruno Frediani, Mauro Galeazzi, Gian Marco Tosi, Antonio Vitale, Giacomo Emmi, Stefano Gentileschi, and Daniela Bacherini, “Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study,” Clinical Rheumatology, vol. 36, no. 1, pp. 191–197, 2016. View at Publisher · View at Google Scholar
  • Cristina Mugheddu, Laura Atzori, Maria Del Piano, Astrid Lappi, Monica Pau, Severino Murgia, Ignazio Zucca, and Franco Rongioletti, “Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis,” Dermatologic Therapy, pp. e12527, 2017. View at Publisher · View at Google Scholar
  • Marcus de Luca Maciel, Marcelo Novello, and Fabricio Souza Neves, “Short-term efficacy of abatacept in the treatment of refractory ocular and cutaneous Behçet’s disease,” Rheumatology Advances in Practice, vol. 1, no. 1, 2017. View at Publisher · View at Google Scholar
  • A. C. Desbois, H. Vallet, F. Domont, C. Comarmond, P. Cacoub, and D. Saadoun, “Management of severe complications in Behçet’s disease with TNF inhibitors,” Expert Opinion on Biological Therapy, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Romina Gallizzi, Dominique De Vivo, Simona Valenti, Caterina Pidone, Carmelo Romeo, Rosario Caruso, and Claudio Romano, “Intestinal and neurological involvement in Behcet disease: a clinical case,” Italian Journal of Pediatrics, vol. 43, no. 1, 2017. View at Publisher · View at Google Scholar
  • D. P. Kidd, “Neurological complications of Behçet’s syndrome,” Journal of Neurology, 2017. View at Publisher · View at Google Scholar
  • Masaki Takeuchi, Nobuhisa Mizuki, Akira Meguro, Michael J Ombrello, Yohei Kirino, Colleen Satorius, Julie Le, Mary Blake, Burak Erer, Tatsukata Kawagoe, Duran Ustek, Ilknur Tugal-Tutkun, Emire Seyahi, Yilmaz Ozyazgan, Inês Sousa, Fereydoun Davatchi, Vânia Francisco, Farhad Shahram, Bahar Sadeghi Abdollahi, Abdolhadi Nadji, Niloofar Mojarad Shafiee, Fahmida Ghaderibarmi, Shigeaki Ohno, Atsuhisa Ueda, Yoshiaki Ishigatsubo, Massimo Gadina, Sofia A Oliveira, Ahmet Gül, Daniel L Kastner, and Elaine F Remmers, “Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility,” Nature Genetics, vol. 49, no. 3, pp. 438–443, 2017. View at Publisher · View at Google Scholar
  • Nicola Maruotti, Addolorata Corrado, and Francesco Paolo Cantatore, “Anti-Angiogenic Effects of Anti–Tumor Necrosis Factor α Agents in the Treatment of Behçet Disease,” Clinical Medicine Insights: Therapeutics, vol. 9, pp. 1179559X1774532, 2017. View at Publisher · View at Google Scholar
  • Romina Gallizzi, Caterina Pidone, Luca Cantarini, Martina Finetti, Marco Cattalini, Giovanni Filocamo, Antonella Insalaco, Donato Rigante, Rita Consolini, Maria Cristina Maggio, Adele Civino, Silvana Martino, Alma Nunzia Olivieri, Giovanna Fabio, Serena Pastore, Angela Mauro, Diana Sutera, Giuseppe Trimarchi, Nicolino Ruperto, Marco Gattorno, and Rolando Cimaz, “A national cohort study on pediatric Behçet’s disease: cross-sectional data from an Italian registry,” Pediatric Rheumatology, vol. 15, no. 1, 2017. View at Publisher · View at Google Scholar
  • Luisa Costa, Carlo Perricone, Maria Sole Chimenti, Antonio Del Puente, Paolo Caso, Rosario Peluso, Paolo Bottiglieri, Raffaele Scarpa, and Francesco Caso, “Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence,” Drugs in R&D, 2017. View at Publisher · View at Google Scholar
  • Lela A. Lee, and Victoria P. Werth, “Skin and Rheumatic Diseases,” Kelley and Firestein's Textbook of Rheumatology, pp. 625–644, 2017. View at Publisher · View at Google Scholar
  • Giuseppe Lopalco, Donato Rigante, Vincenzo Venerito, Claudia Fabiani, Rossella Franceschini, Michele Barone, Giovanni Lapadula, Mauro Galeazzi, Bruno Frediani, Florenzo Iannone, and Luca Cantarini, “Update on the Medical Management of Gastrointestinal Behçet’s Disease,” Mediators of Inflammation, vol. 2017, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Francesco Caso, Luisa Costa, Valeria Nucera, Giuseppe Barilaro, Ignazio Francesco Masala, Rossella Talotta, Paolo Caso, Raffaele Scarpa, Piercarlo Sarzi-Puttini, and Fabiola Atzeni, “From autoinflammation to autoimmunity: old and recent findings,” Clinical Rheumatology, 2018. View at Publisher · View at Google Scholar
  • Mingxue Sun, Yuyan Yang, Wenqi Meng, Qingqiang Xu, Fengwu Lin, Yongchun Chen, Jie Zhao, and Kai Xiao, “Advanced biotherapy for the treatment of sulfur mustard poisoning,” Chemico-Biological Interactions, 2018. View at Publisher · View at Google Scholar
  • Susanna Esposito, Nicola Principi, Paolo Calabresi, and Donato Rigante, “An evolving redefinition of autoimmune encephalitis,” Autoimmunity Reviews, 2018. View at Publisher · View at Google Scholar
  • Ana Urruticoechea-Arana, Tatiana Cobo-Ibáñez, Virginia Villaverde-García, Montserrat Santos Gómez, Estíbaliz Loza, Kelly Vargas-Osorio, Leslie Fariñas Padrón, Federico Diaz-Gonzalez, Vanesa Calvo-Río, and Ricardo Blanco, “Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review,” Rheumatology International, 2018. View at Publisher · View at Google Scholar
  • Fabiola Atzeni, Francesco Caso, Luisa Costa, Piercarlo Sarzi-Puttini, and Ignazio F. Masala, “Conventional and Biological DMARDs in Systemic Rheumatic Diseases,” Surgery in Rheumatic and Musculoskeletal Disease, vol. 15, pp. 161–182, 2018. View at Publisher · View at Google Scholar
  • Donato Rigante, “The broad-ranging panorama of systemic autoinflammatory disorders with specific focus on acute painful symptoms and hematologic manifestations in children,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 10, no. 1, 2018. View at Publisher · View at Google Scholar
  • Francisco Galeano-Valle, Pablo Demelo-Rodriguez, Luís Álvarez-Sala-Walther, Blanca Pinilla-Llorente, Miguel Jesús Echenagusia-Boyra, Hugo Rodriguez-Abella, and Jorge Del-Toro-Cervera, “Intracardiac thrombosis in Behçet's Disease successfully treated with immunosuppressive agents: A case of vascular pathergy phenomenon,” Intractable & Rare Diseases Research, 2018. View at Publisher · View at Google Scholar
  • I. Ksiaa, N. Abroug, M. Kechida, S. Zina, B. Jelliti, S. Khochtali, S. Attia, and M. Khairallah, “Œil et maladie de Behçet,” Journal Français d'Ophtalmologie, 2019. View at Publisher · View at Google Scholar
  • Ahmet Ilbay, Abdulsamet Erden, Alper Sari, Berkan Armagan, Burak Yasin Aktas, Ertugrul Cagri Bolek, Umut Kalyoncu, and Omer Karadag, “Successful Treatment of Amyloid A–Type Amyloidosis Due to Behçet Disease With Tocilizumab,” JCR: Journal of Clinical Rheumatology, vol. 25, no. 4, pp. 43–45, 2019. View at Publisher · View at Google Scholar
  • K. Belkhadir, N. Boutimzine, M. Laghmari, A. Amazouzi, S. Tachfouti, and O. Cherkaoui, “Facteurs pronostiques de l’atteinte oculaire dans la maladie de Behçet,” Journal Français d'Ophtalmologie, 2019. View at Publisher · View at Google Scholar
  • Dimitri Poddighe, Zaure Mukusheva, Kaisar Dauyey, and Maikesh Assylbekova, “Adalimumab in the treatment of pediatric Behçet’s disease: case-based review,” Rheumatology International, 2019. View at Publisher · View at Google Scholar
  • I. Ksiaa, N. Abroug, M. Kechida, S. Zina, B. Jelliti, S. Khochtali, S. Attia, and M. Khairallah, “Eye and Behçet's disease,” Journal Français d'Ophtalmologie, 2019. View at Publisher · View at Google Scholar
  • Kinya Hisanaga, “The etiology, diagnosis, and treatment of neurological complications in Behçet disease and its related disorder Sweet disease,” Rinsho Shinkeigaku, vol. 59, no. 1, pp. 1–12, 2019. View at Publisher · View at Google Scholar
  • Seza Özen, Selcan Demir, and Hafize Emine Sönmez, “Vasculitis: Decade in review,” Current Rheumatology Reviews, vol. 15, no. 1, pp. 14–22, 2019. View at Publisher · View at Google Scholar